Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines
about
Plague Vaccine Development: Current Research and Future TrendsBacteriophages and Their Immunological Applications against Infectious Threats.Deletion of Braun lipoprotein and plasminogen-activating protease-encoding genes attenuates Yersinia pestis in mouse models of bubonic and pneumonic plague.Bacteriophage T4 can produce progeny virions in extremely slowly growing Escherichia coli host: comparison of a mathematical model with the experimental data.Combinational deletion of three membrane protein-encoding genes highly attenuates yersinia pestis while retaining immunogenicity in a mouse model of pneumonic plague.Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.Highly Effective Soluble and Bacteriophage T4 Nanoparticle Plague Vaccines Against Yersinia pestis.Phage-Enabled Nanomedicine: From Probes to Therapeutics in Precision MedicinePlague Vaccines: Status and Future.Genetically modified bacteriophages in applied microbiology.A Bivalent Anthrax-Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, Bacillus anthracis and Yersinia pestis.Engineering of Bacteriophage T4 Genome Using CRISPR-Cas9.Bacteriophage T4 as a Nanoparticle Platform to Display and Deliver Pathogen Antigens: Construction of an Effective Anthrax Vaccine.Bacteriophages of Yersinia pestis.Unexpected evolutionary benefit to phages imparted by bacterial CRISPR-Cas9.Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia.
P2860
Q28066875-AE805664-952B-4612-955F-2FE8E5CF3946Q30234522-C3FA2BDC-738A-441E-BA7B-72E9FAEDE691Q33603015-1A3E3660-86E6-4669-A96D-4A73167BB4B1Q35081370-63A98794-5B6C-4046-8FD6-1F9EB0AD71B4Q35187610-6F8A22D3-A9F1-484C-8117-F81E6C2012B7Q36316792-AC711D9B-D894-4129-820A-72DE634EC560Q37067254-7DD8C3A3-3E40-460E-B32E-3671009A87B0Q37523428-4A7F642F-1F0D-4932-83B0-44452AA23BF2Q37644025-FE8FB73E-EB99-4712-9627-F305545CA03EQ38813137-5B6319CC-1728-45DB-AC49-E5AC324676C0Q38870317-62DD46C3-F887-487B-832A-ACFFD0F06E87Q40140655-20CD19D0-5C54-45C8-80AA-50AA0CA9F7E4Q40155162-A93752CC-9C29-4340-9251-508C3C928FC6Q40259573-B1278305-7641-466E-BD32-10AD58810AB4Q40512089-43996D29-C00A-4B4C-8D8E-6F7A5ED6ED7AQ49864566-F17DAB38-6F1B-4481-A47B-8D1E6A4EE4B4Q55361721-B9F7B2D0-3793-4E3B-854E-59CE855AD1A8
P2860
Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Mutated and bacteriophage T4 n ...... ext generation plague vaccines
@ast
Mutated and bacteriophage T4 n ...... ext generation plague vaccines
@en
Mutated and bacteriophage T4 n ...... ext generation plague vaccines
@nl
type
label
Mutated and bacteriophage T4 n ...... ext generation plague vaccines
@ast
Mutated and bacteriophage T4 n ...... ext generation plague vaccines
@en
Mutated and bacteriophage T4 n ...... ext generation plague vaccines
@nl
prefLabel
Mutated and bacteriophage T4 n ...... ext generation plague vaccines
@ast
Mutated and bacteriophage T4 n ...... ext generation plague vaccines
@en
Mutated and bacteriophage T4 n ...... ext generation plague vaccines
@nl
P2093
P2860
P921
P1433
P1476
Mutated and bacteriophage T4 n ...... ext generation plague vaccines
@en
P2093
Ashok K Chopra
Christina J van Lier
Linsey A Yeager
Marthandan Mahalingam
Michelle L Kirtley
Venigalla B Rao
P2860
P304
P356
10.1371/JOURNAL.PPAT.1003495
P407
P577
2013-01-01T00:00:00Z